Recapitulation of Werner syndrome sensitivity to camptothecin by limited knockdown of the WRN helicase/exonuclease.

WRN is a RecQ helicase with an associated exonuclease activity important in DNA metabolism, including DNA replication, repair and recombination. In humans, deficiencies in WRN function cause the segmental progeroid Werner syndrome (WS), in which patients show premature onset of many hallmarks of nor...

Full description

Bibliographic Details
Main Authors: Bird, J, Jennert-Burston, K, Bachler, M, Mason, P, Lowe, J, Heo, S, Campisi, J, Faragher, R, Cox, L
Format: Journal article
Language:English
Published: 2012
_version_ 1826277866212425728
author Bird, J
Jennert-Burston, K
Bachler, M
Mason, P
Lowe, J
Heo, S
Campisi, J
Faragher, R
Cox, L
author_facet Bird, J
Jennert-Burston, K
Bachler, M
Mason, P
Lowe, J
Heo, S
Campisi, J
Faragher, R
Cox, L
author_sort Bird, J
collection OXFORD
description WRN is a RecQ helicase with an associated exonuclease activity important in DNA metabolism, including DNA replication, repair and recombination. In humans, deficiencies in WRN function cause the segmental progeroid Werner syndrome (WS), in which patients show premature onset of many hallmarks of normal human ageing. At the cellular level, WRN loss results in rapid replicative senescence, chromosomal instability and sensitivity to various DNA damaging agents including the topoisomerase inhibitor, camptothecin (CPT). Here, we investigate the potential of using either transient or stable WRN knockdown as a means of sensitising cells to CPT. We show that targeting WRN mRNA for degradation by either RNAi or hammerhead ribozyme catalysis renders human fibroblasts as sensitive to CPT as fibroblasts derived from WS patients, and furthermore, we find altered cell cycle transit and nucleolar destabilisation in these cells following CPT treatment. Such WS-like phenotypes are observed despite very limited decreases in total WRN protein, suggesting that levels of WRN protein are rate-limiting for the cellular response to camptothecin. These findings have major implications for development of anti-WRN agents that may be useful in sensitising tumour cells to clinically relevant topoisomerase inhibitors.
first_indexed 2024-03-06T23:35:21Z
format Journal article
id oxford-uuid:6d788934-6530-4fd0-8f1c-62cead62ad1b
institution University of Oxford
language English
last_indexed 2024-03-06T23:35:21Z
publishDate 2012
record_format dspace
spelling oxford-uuid:6d788934-6530-4fd0-8f1c-62cead62ad1b2022-03-26T19:17:59ZRecapitulation of Werner syndrome sensitivity to camptothecin by limited knockdown of the WRN helicase/exonuclease.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:6d788934-6530-4fd0-8f1c-62cead62ad1bEnglishSymplectic Elements at Oxford2012Bird, JJennert-Burston, KBachler, MMason, PLowe, JHeo, SCampisi, JFaragher, RCox, LWRN is a RecQ helicase with an associated exonuclease activity important in DNA metabolism, including DNA replication, repair and recombination. In humans, deficiencies in WRN function cause the segmental progeroid Werner syndrome (WS), in which patients show premature onset of many hallmarks of normal human ageing. At the cellular level, WRN loss results in rapid replicative senescence, chromosomal instability and sensitivity to various DNA damaging agents including the topoisomerase inhibitor, camptothecin (CPT). Here, we investigate the potential of using either transient or stable WRN knockdown as a means of sensitising cells to CPT. We show that targeting WRN mRNA for degradation by either RNAi or hammerhead ribozyme catalysis renders human fibroblasts as sensitive to CPT as fibroblasts derived from WS patients, and furthermore, we find altered cell cycle transit and nucleolar destabilisation in these cells following CPT treatment. Such WS-like phenotypes are observed despite very limited decreases in total WRN protein, suggesting that levels of WRN protein are rate-limiting for the cellular response to camptothecin. These findings have major implications for development of anti-WRN agents that may be useful in sensitising tumour cells to clinically relevant topoisomerase inhibitors.
spellingShingle Bird, J
Jennert-Burston, K
Bachler, M
Mason, P
Lowe, J
Heo, S
Campisi, J
Faragher, R
Cox, L
Recapitulation of Werner syndrome sensitivity to camptothecin by limited knockdown of the WRN helicase/exonuclease.
title Recapitulation of Werner syndrome sensitivity to camptothecin by limited knockdown of the WRN helicase/exonuclease.
title_full Recapitulation of Werner syndrome sensitivity to camptothecin by limited knockdown of the WRN helicase/exonuclease.
title_fullStr Recapitulation of Werner syndrome sensitivity to camptothecin by limited knockdown of the WRN helicase/exonuclease.
title_full_unstemmed Recapitulation of Werner syndrome sensitivity to camptothecin by limited knockdown of the WRN helicase/exonuclease.
title_short Recapitulation of Werner syndrome sensitivity to camptothecin by limited knockdown of the WRN helicase/exonuclease.
title_sort recapitulation of werner syndrome sensitivity to camptothecin by limited knockdown of the wrn helicase exonuclease
work_keys_str_mv AT birdj recapitulationofwernersyndromesensitivitytocamptothecinbylimitedknockdownofthewrnhelicaseexonuclease
AT jennertburstonk recapitulationofwernersyndromesensitivitytocamptothecinbylimitedknockdownofthewrnhelicaseexonuclease
AT bachlerm recapitulationofwernersyndromesensitivitytocamptothecinbylimitedknockdownofthewrnhelicaseexonuclease
AT masonp recapitulationofwernersyndromesensitivitytocamptothecinbylimitedknockdownofthewrnhelicaseexonuclease
AT lowej recapitulationofwernersyndromesensitivitytocamptothecinbylimitedknockdownofthewrnhelicaseexonuclease
AT heos recapitulationofwernersyndromesensitivitytocamptothecinbylimitedknockdownofthewrnhelicaseexonuclease
AT campisij recapitulationofwernersyndromesensitivitytocamptothecinbylimitedknockdownofthewrnhelicaseexonuclease
AT faragherr recapitulationofwernersyndromesensitivitytocamptothecinbylimitedknockdownofthewrnhelicaseexonuclease
AT coxl recapitulationofwernersyndromesensitivitytocamptothecinbylimitedknockdownofthewrnhelicaseexonuclease